GCP
TBIO

GSA Capital Partners’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

GSA Capital Partners’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-21,857
Closed -$297K – 1750
2020
Q3 		$297K Buy
+21,857
New +$337K 0.05% 742
2019
Q4 		– Sell
-22,359
Closed -$222K – 1848
2019
Q3 		$222K Buy
+22,359
New +$211K 0.03% 1118

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GSA Capital Partners's TBIO Position: Q4 2020 in Review

GSA Capital Partners sold out of Translate Bio, Inc. Common Stock (TBIO) in Q4 2020, closing a stake of 21,857 shares — an estimated $297K sold.

GSA Capital Partners first reported a position in TBIO in Q3 2019 and held it in 2 quarters. The position peaked at $297K in Q3 2020. 150 funds tracked by Wall St. Rank hold TBIO as of Q4 2020.

  • GSA Capital Partners reported no remaining Translate Bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • GSA Capital Partners sold 21,857 Translate Bio, Inc. Common Stock shares in Q4 2020, an estimated $297K.
  • GSA Capital Partners first reported a position in Translate Bio, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • GSA Capital Partners's Translate Bio, Inc. Common Stock position peaked at $297K in Q3 2020.
  • 150 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q4 2020.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.